Management & Outcomes of Single Subsegmental Pulmonary Embolus: A Retrospective Audit at North Shore Hospital, New Zealand.

Link to article at PubMed

Related Articles

Management & Outcomes of Single Subsegmental Pulmonary Embolus: A Retrospective Audit at North Shore Hospital, New Zealand.

Intern Med J. 2014 Jun 18;

Authors: Mehta D, Barnett M, Zhou L, Woulfe T, Rolfe-Vyson V, Rowland V, Simpson D, Merriman E

Abstract
BACKGROUND: It is unknown whether filling defects in subsegmental arteries on multidetector computed tomography pulmonary angiography (CTPA) correlate with clinically relevant subsegmental PE on pulmonary angiography. Current guidelines do not differentiate between PE in segmental and subsegmental vessels, and many patients receive at least 3 months anticoagulation. The strategy employed at North Shore Hospital in haemodynamically stable patients with single subsegmental PE is to perform bilateral lower leg compression ultrasound (CUS). Anticoagulation is withheld if CUS is negative; a bilateral CUS is repeated in 7-10 days.
AIMS: The aim of this retrospective audit was to ensure our current management strategy is safe.
METHODS: All diagnoses of single subsegmental PE between June 2005-June 2013 were included. The primary outcome was the rate of venous thromboembolism (VTE) recurrence within three months of single subsegmental PE diagnosis. Secondary outcomes were rates of major/minor bleeding, and all-cause mortality.
RESULTS: Thirty-two patients were included - 20 were treated with anticoagulation; 12 were managed with observation/serial bilateral lower limb compression ultrasound (CUS). None of the patients in either group had VTE recurrence by 3 months. No bleeding episodes were observed in the observation group; there was a 10% major bleeding rate (n=2) in the treatment group. One death occurred in each group, neither of which was attributed to VTE.
CONCLUSION: Withholding anticoagulation in patients with single subsegmental PE and negative serial bilateral CUS appear to be a safe and effective management strategy, with a low risk of VTE recurrence.

PMID: 24942202 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *